Beta Amyloid Suppresses the Expression of the Vitamin D Receptor Gene and Induces the Expression of the Vitamin D Catabolic Enzyme Gene in Hippocampal Neurons
Authors:
- Erdinç DursunEDErdinç Dursun
- Duygu Gezen-AkDGDuygu Gezen-Ak
- Selma YilmazerSYSelma Yilmazer
- 7 June 2013
- journal article
- research article
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 36 (1-2) , 76-86
Abstract
Background/Aims: The beta amyloid aggregations present in Alzheimer's disease affect neurons through various toxic alterations. The aim of this study was to determine the expression of the vitamin D receptor (VDR), 25-hydroxyvitamin D3 24-hydroxylase (an accelerator of vitamin D catabolism), and the L-type voltage-sensitive calcium channel A1C (LVSCC-A1C) in hippocampal neurons in response to beta amyloid and vitamin D treatments to test the protective effects of vitamin D and the probable effects of beta amyloid on vitamin D catabolism. Methods: The expression of the VDR, 24-hydroxylase (24OHase) and LVSCC-A1C mRNAs were studied using quantitative real-time polymerase chain reaction, and the cytotoxicity levels were determined by an ELISA in primary hippocampal neuron cultures prepared from Sprague-Dawley rat embryos. Results: Our results demonstrated that beta amyloid suppressed the expression of VDR mRNA and induced the expression of 24OHase and LVSCC-A1C mRNAs. Conclusion: Beta amyloid may disrupt the vitamin D-VDR pathway and cause defective utilization of vitamin D by suppressing the level of the VDR and elevating the level of 24OHase.Keywords
This publication has 50 references indexed in Scilit:
- Adult hippocampal neurogenesis and its role in Alzheimer's diseaseMolecular Neurodegeneration, 2011
- Vitamin D: MetabolismEndocrinology and Metabolism Clinics of North America, 2010
- Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseasesPsychoneuroendocrinology, 2009
- Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and diseaseFrontiers in Neuroendocrinology, 2009
- Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the storeAging Cell, 2007
- Distribution of the Vitamin D receptor and 1α-hydroxylase in human brainJournal of Chemical Neuroanatomy, 2005
- New clues about vitamin D functions in the nervous systemTrends in Endocrinology & Metabolism, 2002
- l-type calcium channels in the hippocampus and cerebellum of Alzheimer’s disease brain tissueNeurobiology of Aging, 1999
- Amyloid, the presenilins and Alzheimer's diseaseTrends in Neurosciences, 1997
- Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans.Psychological Review, 1992